Mersana Therapeutics (MRSN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist

1.310
-0.180-12.08%

Close Aug 16 16:00 ET

1.291
-0.019-1.45%

Post 17:29 ET

160.70MMarket Cap-1541P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Yahoo FinanceAug 16 07:27 ET
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Analysts Are More Bearish Than They Used To Be
Simply Wall StAug 15 07:49 ET
Express News | Baird Maintains Neutral on Mersana Therapeutics, Lowers Price Target to $3
BenzingaAug 14 07:41 ET
Mersana Therapeutics Analyst Ratings
BenzingaAug 14 07:40 ET · Ratings
BTIG Initiates Mersana Therapeutics(MRSN.US) With Buy Rating, Announces Target Price $6
Moomoo NewsAug 14 07:31 ET · Ratings
Truist Financial Maintains Mersana Therapeutics(MRSN.US) With Buy Rating
Moomoo NewsAug 14 07:31 ET · Ratings

Comments

Moomoo AI

Feb 22 13:53

Despite a recent share price hike, Mersana Therapeutics' P/S ratio lags behind others due to forecasted revenue decline. Without major changes, a drastic stock price rise is unlikely.

Mersana Therapeutics, Inc.'s (NASDAQ:MRSN) Shares Bounce 31% But Its Business Still Trails The Industry

Moomoo AI

Dec 20, 2023 06:43

Mersana Therapeutics forecasted future revenue decline contributes to lower P/S ratio, limiting strong rise potential in share prices. The market expects performance drop, keeping P/S suppressed. For P/S to avoid further fall, top-line growth needs improvement.